New and deleted products

Promo Image

New Products

Products added to MIMS

Promo Image

Deleted Products

Products removed from MIMS

RSS Feed

Latest news

New obesity treatment targets appetite and reward pathways in the brain

New obesity treatment targets appetite and reward pathways in the brain

Mysimba (naltrexone/bupropion) can be used alongside...

Cardiovascular warning for rosacea gel

Cardiovascular warning for rosacea gel

Patients using the topical rosacea treatment brimonidine...

Infographic: GPs urged to ensure patients aware of valproate risks in pregnancy

Infographic: GPs urged to ensure patients aware of valproate risks in pregnancy

Despite wide dissemination of MHRA guidance and resources,...

Eluxadoline: first treatment option for IBS patients with diarrhoea

Eluxadoline: first treatment option for IBS patients with diarrhoea

Truberzi (eluxadoline) is a new orally administered...

New antibody prevents recurrence of Clostridium difficile infection

New antibody prevents recurrence of Clostridium difficile infection

Zinplava (bezlotoxumab) is a human monoclonal antibody...



Featured MIMS resources

Promo Image

Anti-Anginal Preparations

Available formulations of angina drugs, grouped by class.

Promo Image

Management of Crohn's Disease

At-a-glance summary of NICE guidance on Crohn's disease.


Most popular

Antidepressants, a Guide to Switching and Withdrawing

Instructions for changing or stopping antidepressants.

H.pylori: Eradication Regimens (NICE)

Summary of NICE guidance on Helicobacter treatment.

Hormone Replacement Therapy (HRT)

Hormone doses and costs of HRT preparations.

Topical Steroids, Comparison of Potencies and Formulations

Strengths and formulations of topical steroids.

Antibiotic Treatments in Adults, Summary of Regimens

Dose regimens for common bacterial infections.


Manufacturers

Manufacturers

Contact details and drug listings for manufacturers in MIMS


Partner CPD from MIMS Learning

knowledge 0.5 Credits

Initiated, funded and reviewed by Reckitt Benckiser. Date of Preparation: February 2017; UK/E45-NHS/0916/0013j

WEBCAST 1 Credit

Lessons from the Ealing GP Federation Funding for this educational programme has been provided by Bayer, Boehringer Ingelheim and Daiichi Sankyo. None of the companies have had any influence or input into its content.

Webcast 0.5 Credits

Initiated, funded and reviewed by Teva Respiratory. Teva UK Limited, Field House, Station Approach, Harlow, Essex, CM20 2FB

New products coming soon to MIMS

Check back soon to find MIMS listings for the following new drugs:

Brinavess (vernakalant)

Epistatus (midazolam)

Fertavid (follitropin beta) 

Panzyga (human normal immunoglobulin)

Suliqua (insulin glargine/lixisenatide)

Varuby (rolapitant)

Vemlidy (tenofovir alafenamide fumarate)


Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Alert:
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

This site is intended for healthcare professionals.